Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Add filters

Document Type
Year range
NeuroQuantology ; 20(16):1682-1693, 2022.
Article in English | EMBASE | ID: covidwho-2156384


Mucormycosis in people with COVID-19 or who are immunocompromised in any other way has become a worldwide issue, resulting in severe morbidity and mortality. Infection is incapacitating. and deadly, resulting in organ loss and emotional anguish. Mucormycosis is a rare angioinvasive illness that primarily affects immunocompromised people and is caused by the prolife ration of Mucorales. There are no radiographic symptoms. However a diagnosis can be made by microscopically examining materials recovered from necrotizing lesions Because the fungus enters the body through the skin, treatment involves a multidisciplinary approach. The use of the several antifungal medicines available is restricted by resistance and toxicity factors. The lipid formulation of amphotericin-B (liposomal Am-B) is the first-line treatment for mucormycosis in COVID-19 patients. high cost and limited availability have prompted a shift toward surgery, so surgical debridement to remove all necrotic lesions remains the keystone of effective mucormycosis treatment in COVID-19. This study concentrates on the pathophysiology, clinical manifestations, and therapy of HyperglycemiaAndIts Contributing Factors In Patients With Post Covid - 19 Mucormycosis. Copyright © 2022, Anka Publishers. All rights reserved.

Biomedical and Pharmacology Journal ; 13(4):1791-1807, 2020.
Article in English | Scopus | ID: covidwho-1083470


A novel threat to mankind by novel coronavirus infection occurred in December 2019. According to the World Health Organization (WHO) Situation Report-141, 7,039,918 confirmed cases and 404,396 death cases were observed till 9 June 2020 in the different regions of world. Therefore, this article aims to summarize and share the update on the present status of the outbreak and possible treatment options. The present review focuses on latest statistics, diagnostic and preventive measures under study and the future planning of the researchers to discover an effective cure for this threat to the mankind. For carrying out this review, literature searches were performed on, official website of WHO,Centers for Disease Control and Prevention, PubMed, Google scholars, etc. Data from these searches was collected and evaluated for getting the available literature on COVID-19 outbreak and drugs under study. The details of history, virology, epidemiology, possible therapeutic options, associated risk factors and preventive measures related to COVID-19 are compiled here in this review. Along with this, some ongoing clinical trials have also been included in this review in order to conclude the efforts of researchers towards controlling this outbreak. The trajectory and severity of this outbreak can't be predicted at present, but immediate actions are required to be taken in order to develop and implement an effective treatment against the global threat. © 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY). Published by Oriental Scientific Publishing Company.

International Journal of Current Research and Review ; 13(3):113-119, 2021.
Article in English | Scopus | ID: covidwho-1083469


Introduction: A novel threat to mankind occurred in December 2019 which was an outbreak of infection caused by a novel coronavirus (SARS-CoV-2 or 2019-nCoV). The infection was first developed in Wuhan, China, and has affected more than 200 countries around the world till now. Objective: The present study aims to assess the knowledge related to coronavirus disease (COVID-19), risk perception and preventive behaviours among the Pharmacy students in a part of India approximately 3 months after the onset of this outbreak in India. Methods: This survey was conducted from 2nd to 5th of September 2020 with Indian Pharmacy students (1st to 4th year). The knowledge, self-reported preventive behaviours and risk perceptions of COVID-19 were assessed using an online questionnaire. A total of 21 questions were there in the questionnaire in which 14 questions were about knowledge related to COVID-19, 4 items regarding preventive behaviours and 3 about risk perception. Results: A total of 268 participants completed the questionnaire. The participants were under the age group of 15-30 years. A high level of disease-related knowledge was found in the participants (77.66%). On an average 96.1% of participants were practising preventive behaviours. The aggregate score of items in risk perception section was found to be in the moderate range i.e., 5.38 out of 8. A significant negative correlation was obtained between risk perception and preventive behaviours. Conclusion: The trajectory and severity of this outbreak are very high, therefore, effective treatment against this global threat is required to be developed as early as possible. In the present study, a high level of disease-related knowledge and preventive behaviours were observed among the participants with a moderate level of risk perception. © IJCRR.